RDR and economy threaten critical illness products-Defaqto

clock

Critical illness products face a fight for survival as they come under threat from RDR proposals, the economic downturn and a crisis of confidence on claims.

According to Defaqto’s Critical Illness Report 2008, product innovation is key if these products are to flourish in the future. However, recent RDR proposals, which downgraded protection products to the sales category where non or little ‘advice’ is given, may discourage more complex propositions. Another major threat is the economic downturn as many critical illness sales are linked to mortgage sales which are in sharp decline. The report also highlights a crisis of confidence in the protection industry and critical illness in particular. “Bad publicity over claims and alleged ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Protection

The protection gap is not a surprise - treating it as one is

The protection gap is not a surprise - treating it as one is

'This is not mysterious. It is what this market is built to produce'

Tony Müdd
clock 09 September 2026 • 4 min read
Aviva in high value protection proposition launch

Aviva in high value protection proposition launch

Rising demand for IHT planning

Cameron Roberts
clock 25 August 2026 • 2 min read
Advisers are changing their views on joint life cover

Advisers are changing their views on joint life cover

What represents true value for the client?

Alan Lakey
clock 11 August 2026 • 3 min read